D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAZR
3401
CALL
DELISTED
Luminar Technologies
LAZR
| $642K | ﹤0.01% |
223,800
+28,800
| +15% | +$109K |
|
|
OPI
3402
DELISTED
Office Properties Income Trust
OPI
| $641K | ﹤0.01% |
2,596,642
-1,217,870
| -32% | -$342K |
|
3403
PUT
Capri Holdings
CPRI
$1.82B
| $641K | ﹤0.01% |
+36,200
| New | +$596K |
|
3404
PUT
Innovative Industrial Properties
IIPR
$1.78B
| $641K | ﹤0.01% |
+11,600
| New | +$635K |
|
3405
Omega Flex
OFLX
$305M
| $640K | ﹤0.01% |
19,760
+4,983
| +34% | +$160K |
|
3406
Papa John's
PZZA
$997M
| $640K | ﹤0.01% |
+13,068
| New | +$533K |
|
3407
Caesars Entertainment
CZR
$6.1B
| $639K | ﹤0.01% |
22,502
-61,200
| -73% | -$1.66M |
|
3408
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.33B
| $637K | ﹤0.01% |
6,483
| – | – |
|
3409
Silgan Holdings
SLGN
$4.92B
| $637K | ﹤0.01% |
+11,753
| New | +$621K |
|
3410
Twilio
TWLO
$29.5B
| $631K | ﹤0.01% |
5,071
-950,065
| -99% | -$101M |
|
3411
Cytokinetics
CYTK
$10.9B
| $631K | ﹤0.01% |
19,084
+5,782
| +43% | +$201K |
|
3412
CALL
Galicia Financial Group
GGAL
$8.03B
| $630K | ﹤0.01% |
12,500
-75,500
| -86% | -$4.32M |
|
3413
CALL
PagSeguro Digital
PAGS
$2.62B
| $629K | ﹤0.01% |
65,300
| – | – |
|
3414
Tucows
TCX
$95.5M
| $627K | ﹤0.01% |
31,816
-987
| -3% | -$17.7K |
|
3415
Xcel Energy
XEL
$50.4B
| $627K | ﹤0.01% |
9,200
-4,500
| -33% | -$312K |
|
3416
Harmony Gold Mining
HMY
$9.92B
| $626K | ﹤0.01% |
44,816
-637,807
| -93% | -$9.64M |
|
3417
ImmunityBio
IBRX
$7.32B
| $626K | ﹤0.01% |
+237,147
| New | +$638K |
|
|
FSUN
3418
FirstSun Capital Bancorp
FSUN
$1.63B
| $624K | ﹤0.01% |
+17,957
| New | +$629K |
|
3419
Lifeway Foods
LWAY
$466M
| $623K | ﹤0.01% |
25,293
-3,807
| -13% | -$90.2K |
|
3420
Avantis US Small Cap Equity ETF
AVSC
$3.06B
| $623K | ﹤0.01% |
12,083
-400
| -3% | -$19.3K |
|
3421
Invesco S&P 500 Equal Weight Utilities ETF
RSPU
$551M
| $623K | ﹤0.01% |
8,761
-2,885
| -25% | -$202K |
|
3422
CALL
Viking Therapeutics
VKTX
$4.05B
| $623K | ﹤0.01% |
23,500
| – | – |
|
3423
Park Aerospace
PKE
$785M
| $622K | ﹤0.01% |
42,122
-3,516
| -8% | -$47.6K |
|
3424
Invesco S&P MidCap 400 Pure Value ETF
RFV
$334M
| $620K | ﹤0.01% |
5,133
| – | – |
|
3425
CALL
ChargePoint
CHPT
$140M
| $617K | ﹤0.01% |
43,900
| – | – |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.